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Objectives. The objective of this study was to determine the 
frequency of left atrial thrombus in patients with acute atrial 
fibrillation. 
Bockground. It is commonly assumed but unproved that left 
atrial tbrombus in patients with atrial fibrillation begins to form 
after the onset of atrial fibrillation and tbat it requires 23 days to 
form. Thus, patients with acute atrial fibrillation (i.e., <3 days) 
frequently undergo cardioversion without anticoagulation prophy 
laxis. 
f+4eHto& Three hundred seventeen patients (250 men, 67 
women; mean [“SD] age 64 -t 12 years) with acute (n = 143) or 
chronic (n = 174) atrial fibrillation were studied by two- 
dimensional transesophageal echocardiography. 
Re.&s. Left atrial appendage thrombus was present in 20 
patients (14%) with acute and 47 patients (27%, p e: 0.01) with 
chronic atrial fibrillation. In patients with a recent embolic event, 
the frequency of left atrial appendage thrombus did not dilfer 
between those with acute (5 [21%] of 24) and those with chronic 
(12 [23%] of 52, p = NS) atrial fibrillation. patients with acute 
Atria1 fibrillation is a potentially serious and common cardiac 
arrhythmia that occurs in 2% to 4% of adults XIO years of age 
(1.2). Atrial fibrillation is associated with a high risk of systemic 
embolism, congestive heart failure and death (3-5). The 
appropriate management of patients with atria1 fibrillation to 
reduce morbidity and mortality remains a clinical challenge. 
Although unproved, the postulate that converting atrial fibril- 
lation to sinus rhythm will reduce morbid events and prolong 
survival has shaped the clinical management of these patients 
(6). I Jnfortunately, cardioversion of atria1 fibrillation is asso- 
ciated with a small but significant incidence of systemic embo- 
lism (7-10). Although no definitive study has been reported, 
several earlier (7) and recent (S-10) studies support the 
recommendation of the American College of Chest Physicians 
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versus chronic atrial fibrillation, respectively, did not differ (p = 
NS) in mean age (64 + 13 vs. 65 + 11 years). frequency of 
concentric left ventricular hypertropby (32% vs. 26%), hyperten- 
sion (32% vs. 41%), coronary artery disease (35% vs. 3Y%), 
congestive heart failure (43% vJ. 48%), mitral stenosis (4% vs. 7%) 
or mitral valve replacement (1.4% vs. 6%). The minimally detect- 
able difference in proportions between patients with acute and 
chronic atrial fibrillation based on a power of 0.80 and base 
proportion of 0.20 was 14%. 
Conclusions. Left atrial thrombus does occur in patients with 
acute atrial fibrillation ~3 days in duration. The frequency of left 
atrial thrombus in patients with recent emboli is comparable 
between those with acute and chronic atrial fibrillation. These 
data suggest hat patients with acute atrial fibrillation for <3 days 
require anticoagulation prophylaxis or evaluation by transesoph- 
ageal echocardiography before cardioversion and should not be 
assumed to be free of left atrial thrombus. 
(J ;Im Co!l Grdiol 1995;25:452-9) 
for anticoagulation in patients before elective cardLxersion of 
atria1 fibrillation of ~3 days in duration (11). 
The rationale for not recommending anticoagdation before 
cardioversion in patients with atrial fibrillation of ~3 days in 
duration is based on the assumption that a left atria1 thrombus 
forms after the onset of atria1 fibrillation and requires 48 to 
72 h to form. However, we are unaware of any studies 
reporting the frequency of left atria1 thrombus in patients with 
atria1 fibrillation of <3 days in duration. Recent studies 
utilizing transesophageal echocardiography have demon- 
strated left atrial thrombus in 12% to 26% of patients with 
atria1 fibrillation, but none of these studies has addressed the 
frequency of left atria! thrombus in patients with atria1 fibril- 
lation of <3 days in duration (12-14). In addition, it has 
recently been shown that left atria1 spontaneous echocardio- 
graphic contrast is an independent risk factor for systemic 
embolism (15,16). The frequency of spontaneous echocardio- 
graphic contrast in patients with atria1 fibrillation of <3 days in 
duration is unknown. Therefore, the purpose of this study was 
to determine the frequency of left atria1 thrombus and spon- 
taneous echocardiographic contrast in patients with acute 
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atria1 fibrillation. Patients with acute and chronic atria1 fibril- 
lation were compared to gain insight into potential differences 
in clinical and echocardiographic predictors of left atria! 
thrombus. 
Methods 
Patients. Three hundred seventeen patients (250 men, 69 
women; mean [+SD] age 64 f 12 years, range 25 to 87j who 
met inclusion and exclusion criteria were enrolled from August 
1989 to December 1993. Inclusion criteria included atrial fibrilla- 
tion documented by a 12-lead electrocardiogram (ECG), referral 
to the laboratory for a clinically indicated transesophageal echo- 
cardiographic study and atrial fibrillation at the time of trans- 
esophageal echocardiography. Exclusion criteria included inabil- 
ity to determine duration of atrial fibrillation or technically 
inadequate assessment of the left or right atria by transesophageal 
echocardiography. The duration of atrial fibrillation was deter- 
mined clinically by the abrupt onset of new or worsening persis- 
tent cardiovascular symptoms (i.e., palpitations, dyspnea, angina, 
dizziness), electrocardiographically documented onset of atrial 
fibrillation while in the hospital or review of previous ECGs in 
patients with long-standing or paroxysmal atrial fibrillation. The 
duration of atria1 fibrillation in patients with paroxysmal arrhyth- 
mia was determined as the aggregate duration of previous and 
present episodes. Atrial fibrillation of <3 days in duration and of 
new onset was defined as acute (n = 143) and that of ~3 days in 
duration defined as chronic (n = 174). 
Additional clinical information obtained from al! patients 
included the presence or absence of systemic hypertension 
(i.e., systolic blood pressure >160 mm Hg or diastolic blood 
pressure >90 mm Hg, or both, requiring treatment), coronary 
artery disease (documented tij; previous cardiac catheteriza- 
tion, myocardiai infarction or classic angina pectoris), conges- 
tive heart failure or recent (i.e., within 7 days of transesopha- 
geai echocardiography) systemic emboli (i.e., nonhemorrhagic 
and nonlacunar stroke, transient ischemic attack or peripheral 
emboli). Cerebrovascular accident or stroke was defined as the 
abmpt onset of a focal motor, sensory, cranial nerve, visual or 
speech deficit confirmed by examination of a neurologist and 
lasting ~24 h. Transient ischemic attack was defined as sudden 
onset of a focal neurologic deficit lasting ~24 h and in the 
disliltiution of a major cerebral artery. In general, in patients 
presenting with cerebrovascular accident or transient ischemic 
attack, computed tomographic brain scan was done within 48 h 
and repeated 7 days later. Lacunar infarction was defined as 
either a head computed tomographic scan showing a <1.5-cm 
hypodense deep infarction or clinL+! findings typical of lacu- 
nar infarction (i.e., pure motor or sensory stroke, dysarthria- 
incoordination hand syndrome, etc.) and systemic hyperten- 
sion if there was no computed tomographic brain scan lesion. 
Peripheral systemic embolus was defined as abqpt occlusion 
of an artery supplying the legs, arms or viscera documented by 
examination, noninvasive Doppler imaging, angiography or 
surgical inspection. 
Aspirin use and anticoagulation status were determined. 
Anticoagulation was considered therapeutic if prothrombin 
time was 21.5 times normal or activated partial thromboplas- 
tin time was 22 times normal in patients receiving warfarin or 
heparin, respectively. Seventy-six patients had a systemic em- 
bolic event. The predominant etiologies predisposing to atria1 
fibrillation were coronary artery disease (n = 99), systemic 
hypertension (n = 49), severe mitral regurgitation (n = 33), 
idiopathic dilated cardiomyopathy (n = 26), alcohol abuse 
(n = 21), mitral stenosis (n = lg), valvular heart disease (n = 
12) requiring prior mitral valve (n = 8) or aortic valve (n = 4) 
prosthetic valve replacement, acute exacerbation of chronic 
obstructive pulmonary disease (n = 12), severe tricuspid 
regurgitation (n = 7), mitral valve prolapse (n = S), pulmonary 
emboli (n = 5), hypertrophic obstructive cardiomyopathy (n = 
3), sepsis (n = 3), myocarditis (n = 2), severe aortic insuffi- 
ciency (n = 2), aortic stenosis (n = l), constrictive pericarrlitis 
(n = l), postoperative state (n = 3), hyperthyroidism (n = 1) 
and congenital heart disease (n = 3). Eleven patients (3.5%) 
had no identifiable cardiac or noncardiac etiology of atria1 
fibrillation (i.e., lone atria1 htrillation). 
Tramesophageal echocardiography. Transesophageal echo- 
cardiography was performed with commercially available echo- 
cardiography machines (models 77020 and Sonos 1500, 
Hewlett-Packard, Co.) with a 5.0-MHz, 6Celement phased- 
array monoplane scope (n = X0), 5.0-MHz, 48-element 
phased-array biplane scope (n = 148), or a 5.0-MHz, 64- 
element phased-array omniplane scope (n = 9). After insertion 
of the scope, a comprehensive sequence of two-dimensional 
views was obtained, and color flow and spectral Doppler 
studies were performed in a manner similar to previous 
descriptions (17-19). Transesophageal echocardiographic 
studies included imaging of all valves and cardiac chambers. 
Gain settings were adjusted to minimize gray-noise artifact 
when assessing for spontaneous echocardiographic contrast 
(20). A detailed assessment of the left and right atria1 cham- 
bers and their appendages was performed to delineate intra- 
cardiac thrombus asing multiple views. Thrombus was assessed 
for mobility. Transesophageal M-mode echocardiography was 
performed (21). Contrast (i.e., agitated saline injection) trans- 
esophageal echocardiography was performed to assess the 
patency of the foramen ovale membrane (22). 
Transthoracic echocardiography. Transthoracic echocardi- 
ography was performed with commercially available echocar- 
diographic systems (models 77020 and Sonos 1500, Hewlett- 
Packard) using a 2.5-MHz transducer. Comprehensive 
transthoracic M-mode, two-dimensional, color-flow and spec- 
tral Doppler echocardiography were performed from the stan- 
dard parastemal, apical and subcostal acoustic windows. Trans- 
thoracic and transesophageal echocardiographic studies were 
performed the same day and recorded on half-inch videotape 
for subsequent review and analysis. 
Echocardiographic analysis. Transesophageal and trans- 
thoracic echocardiograms were analyzed in blinded manner. 
Echocardiographic studies were analyzed by investigators un- 
informed of clinical data. Quantitative M-mode or hvo- 
dimensional echocardiographic measurements were made by a 
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single echocardiographer. Qualitative assessment of echocar- 
diograms was done by two experienced echocardiographers 
with results reached by consensus. M-mode transthoracic 
echocardiographic measurements of left atria1 and end- 
diastolic (i.e., peak of QRS R wave) left ventricular diameters 
and septal and posterior wall thicknesses were made according 
to the American Society of Echocardiography recommenda- 
tions (23). Analogous transesophageal M-mode echocardio- 
graphic measurements of the end-diastolic left ventricular 
diameter and wail thicknesses were made in the case of a 
technically difficult transthoracic echocardiographic study. Left 
ventricular mass was calculated from M-mode echocardiogra- 
phy by means of the modified formula of Devereux et al. (24). 
Left ventricular hypertrophy was considered present if left 
ventricular mass divided by body surface area was ~134 g/m* 
in men or ~110 g/m2 in women. Left centricular hypertrophy 
was further characterized as concentric or eccentric if the 
posterior wall thickness times 2 was 245% or <45% of the left 
ventricular end-diastolic diameter, respectively. Qualitative 
determination of left ventricular ejectlon fraction was made 
using two-dimensional transthoracicechocardiographyor trans- 
esophageal echocardiography if transthoracic echocardiogra- 
phy was technically inadequate. Left and right atria1 chambers 
were assessed for the presence of spontaneous echocardio- 
graphic contrast and thrombus. Care was taken to differentiate 
pectinate muscle mimicking thrombus from true thrombus as 
previously described (25). 
Statistical analysis. All results are mean value + 1 SD or 
a proportion of the population size. Potential differences in 
continuous variables among grc?ups wart: assessed by liiipair-ed 
Student t test. A chi-square analysis with continuity correction 
was used to assess for poten:& differences in proportions 
among groups. A multivariate stepwise regression analysis with 
dummy variables for the preserce (1) or absence (0) of discrete 
variables was used to assess for independent predictors of the 
presence of left atria! thrombus or embolic event. A power 
analysis yielded the minimally detectable difference in propor- 
tions based on the sizes of the groups, and assuming alpha 0.05, 
base proportion of 0.20 and a power of 0.80 (26). A p value 
CO.05 was considered statistically significant. 
Results 
Acute versus chronic atrial fibrillation. One hundred 
forty-three patients bad acute and 174 patients had chronic 
atria! fibrillation (Table 1). Mean duration of atrial fibrillation 
at the time of transesophageal echocardiography in patients 
with acute atria! fibrillation was 1.6 ? 0.8 days (range 0 to <3 
days) and 890 zt 1,279 days (range 3 days to 25 years) in 
patients with chronic atria1 fibrillation. In patients with acute 
atria! fibrillation, duration of atria1 fibrillation was ~2 days in 
127 patients and ~2 to <3 days in 16. Patients with acute and 
chronic atria! fibrillation did not differ in terms of age or 
frequency of systemic hypertension, congestive heart failure or 
coronary artery disease. Ten patients with chronic and no 
patients with acute atria! fibrillation had documented paroxys- 
Table 1. Clinical and Echocardiographic Variables in Patients With 
Acute and Chronic Atria1 Fibrillation 
Acute AF Chronic AF P 
(n = 143) (n = 174) Value 
Age W 642 13 652 II 0.78 
Hypertension 46 (32%) II (41s) 0.14 
Congestive HF 6 I (43%) x3 (48%) 0.43 
Coronary disease SO (35%) 67 (39%) OSY 
Lone AF 9 (6%) 2(1”) 0.029 
Anticoag pr+TEE 34 (24%) 73 (42%) O.OlJl 
Anticoag 2 3 wk pre-TEE 3 (2%) 54 (31%) o.ooo1 
Aspirin daily 15 (iO%) 20(11%) 0.92 
LA/LAA-thrombus 20 (14%) 47 (27%) o.cQ72 
LA-SEC 56 (39%) loo (57%) 0.0017 
RA/RAA-thrombus 3 (2%) 2(1%) 0.82 
RA-SEC 26 (18%) 46 (26%) 0.11 
MR 2 moderate 47 (33%) 78 (45%) 0.04 
Mitral stenosis 6 (4%) 12 (7%) 0.43 
MV replacement 2 (1.4%) 10 (6%) 0.085 
LVEF 540% 40 (28%) 68 (39%) 0.05 
LA diameter (cm) 4.21 2 1.04 4.70 2 1.03 OlMO1 
Concentric LVH 46 (32%) 45 (26%) 0.27 
Eccentric LVH 23 (16%) 34 (20%) 0.52 
Data presented are mean value ? SD or number (%) of patients. AF = atrial 
fibrillation; Anticoag = systemic anticoagulation; HF = heart failure; LA = left 
atrial; LAA = left atrial appendage; LVEF = left ventricular ejection fraction; 
LVH = left ventricular hypertrophy; MR = mitral regurgitation; MV = mitral 
valve; RA = right atrial; RAA = right atria1 appendage; SEC = spontaneous 
echocardiographic contrast; TEE = transesophageal echocardiography. 
ma! atria! fibrillation. Although a greater percent of patients 
aith left airia! Grombus ‘wcrc fomid by :ranscsophagea! ccho- 
cardiography among those with chronic (47 patients, or 27%) 
than with acute (20 patients, or 14%, p < 0.01) atria1 fibrilla- 
tion, a clinically important percent of patients with acute atria1 
fibrillation had left atrial thromblls. 
In patients with acute atria! fibrillation, left atria! thrombus 
was confined to the left atria! appendage in 19 patients and to 
the left atria! cavity and appendage in 1 (Fig. 1). In 7 of 20 
patients with acute atria! fibrillation and left atria! thrombus, 
the onset of atria! fibrillation was documented electrocardio- 
graphically in hospital. Of these seven patients, five had mobile 
thrombus and two had immobile thrombus. In one of the 
patients with immobile thrombus, the left atria! appendage 
cavity was completely filled with thrombus (Fig. 2). Case 
examples of patients with atria! thrombus are shown in Figures 
l-3. In patients with acute atria! fibrillation, the percent of 
patients with left atrial thrombus did not differ between those 
with atria! fibrillation 12 days (18 [14%] of 127) and >2 to <3 
days (2 [12.5%] of 16, p = NS) in duration. In patients with 
chronic atria1 fibrillation, 41 had isolated left atrial appendage 
thrombus, S had thrombus of the left atria! cavity and append- 
age, and 1 had a thrombus confined to the left atria! cavity. Left 
atria! spontaneous echocardiographic contrast, delineated us- 
ing transesophageal echocardiography, was more common in 
patients with chronic (57%) than in those with acute (3Y%, p < 
0.002) atria1 fibrillation. Right atria! thromhus was uncommon 
and did not differ in frequency between patients with acute 
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o ire 1. tie-dimensionar echocardiography in 
70-year old man with acute atria1 fibrillation and associated peripheral 
embolus showing a mobile left atrial thrombus (arrow) and mobile 
thrombus near opening (upper arrowhead) and midportion (lower 
arrowhead) of left atrial appendage. A0 = aorta; LA = left atrium; 
PA = pulmonary artery. 
(2%) and chronic (l%, p = NS) atrial fibrillation. Of the five 
patients with right atria1 thrombus, four had isolated right 
atrial appendage thrombus, and one had a right atria1 append- 
age and right atria1 cavity thrombus. None of these patients 
had a pulmonary embolus. All right atria1 thrombi were 
attached to atria1 endocardial surface and not in transit. Right 
atrial spontaneous echocardiographic contrast was less fre- 
quent than left atrial spontaneous echocardiographic contrast 
and did not differ in frequency between patients with acute 
(18%) and chronic (26%, p = NS) atria1 fibrillation. Transtho- 
racic echocardiography failed to delineate left or right atria1 
thrombus or spontaneous echocardiographic contrast in any 
patient. 
Figure 3. Two-dimensional transesophageai echocardiography in a 
78-year old woman with acute atrial fibrillation and peripheral embo- 
lus showing typical ocation of a mobile thrombus (arrow) confined to 
the left atria! appendage, not the left atrium (LA). Other abbreviations 
as in Figure 1. 
A greater percent of patients with C~IUL (42%) than acute 
(24%, p < 0.002) atria1 fibrillation had systemic anticoagula- 
tion before echocardiography. Only three patients (2%) with 
acute atria1 fibrillation were receiving long-standing (i.e., 13 
weeks) anticoagulation. However, 54 (31%) patients with 
chronic atria1 fibrillation were receiving long-standing antico- 
agulation. In patients with anticoagulation, the duration of 
anticoagulation was significantly shorter in patients with acute 
(4 -C 8 days) than chronic (598 -C 1,099 days, p < 0.001) atrial 
fibrillation. Daily aspirin use did not differ behveen the two 
groups and was infrequent. 
The percent of patients with mitral stenosis or previous 
prosthetic mitral valve replacement surgery did not differ 
between natients with acute 2nd chronic atria1 fibrillation and . 
Figure 2. Two-dimensional transesophageal echocardiography in an 
84-year old woman with acute atrial fibrillation caused by coronary 
artery disease showing an immobile dense thrombus (arrows) com- 
pletely filling a dilated lefi atrial appendage. The onset of atria1 
fibrillation was documented electrocardiographically. Abbreviations as 
in Figure 1. 
was small. Moderate or greater mitral regurgitation was com- 
mon in both groups but more frequent in patients with chronic 
(45%) than acute (33%, p < 0.05) atria1 fibrillation. Moderate 
or greater impairment in global left ventricular function (i.e., 
left ventricular ejection fraction 540%) was more common in 
patients with chronic atria1 fibrillation. The frequency of 
&centric or eccentric left ventricular hypertrophi did not 
differ between groups. Paticrtts with chronic atrial fibrillation 
had a larger left atria1 d:ameter than those with acute atria1 
fibrillation. Lone atria1 fibrillation was uncommon in both 
groups but was more frequent in patients with acute (6%) than 
in chronic (l%, p < 0.05) atria1 fibrillation. One of 11 patients 
with lone atria1 fibrillation had a left atria1 appendage throm- 
bus. This patient had chronic atrial fibrillation. 
Acute and chronic atria1 fibrillation: influence of systemic 
emboli. Twenty-four patients with acute and 52 with chronic 
atria1 fibrillation had a recent systemic embolus, defined as a 
nonhemorrhagic and nonlacunar cerebrovascular accident 
(n = 42), transient ischemic attack (n = 22) or peripheral 
embolus (n = 12) (Table 2). In patients without an embolic 
event, left atria1 thrombus was twice as frequent in patients 
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Table 2. Echocardiographic Variables and Anticoagulation Status in Patients With Acute and Chronic Atria1 Ybrillation With and Without 
Recent Systemic Emboli 
Embolic Group Nonembolic Group __- 
Acute AF Chrornc Al- P Acute AF Chronic AF P 
(n = 24) (n = 52) Value (n = 119) (n = 122) Value 
Anticoag pre-TEE 2 (8%) 24 (46%) 0.002 32 (27%) 49 (40%) 0.04 
Anticoag 1 3 weeks prr-TEE 0 (0%) 20 (39%) 0.001 3 (3%) 34 (28%) 0.0001 
Aspirin daily 2 (8%) 9 (17%) 0.49 13(11%) I I (9%) 0.78 
LALAA-thrombus 5 (21%) 12 (23%) 0.94 15 (13%) 35 (29%) 0.0035 
LA-SEC 10 (42%) 30 (58%) 0.29 46 (39%) 70 (57%) 0.0054 
RAIRAA-thrombus 0 (0%) 1 (2%) 0.69 3 (3%) 1 (1%) 0.60 
RA-SEC 4(1X) 17 (33%) 0.24 22 (18%) 29 (24%) 0.40 
MR _z moderate 10 (42%) 18 (35%) 0.74 37 (31%) 60 (49%) 0.0063 
Mitral stenosis 1(4%) 3 (6%) 0.79 5 (4%) 9 (7%) 0.44 
MV replaenlent 0 (0%) 4 (8%) 0.40 2 (2%) 6 (5%) 0.30 
LVEF 540% 3 (13%) 18 (35%) 0.084 37 (31%) 50 (40%) 0.14 
Data presented xre number (%) of patients. Abbreviations as iti Table 1. 
with chronic (29%) than acute (13%, p < 0.005) atria1 
fibrillation. Similarly, left atria1 spontaneous echocardio- 
graphic contrast was more frequent in pztients with chronic 
than acute (57% vs. 39%, p < 0.01) atria1 fibrillation without 
recent embolic event. However, in subjects with a recent 
embolic event, the frequency of left atria1 thrombus or left 
atria? spontaneous echocardiographic contrast did not differ 
between patients with acute and chronic atria1 fibrillation. 
Righr atriai thrombus was uncommon and did not differ in 
frequency among the groups. The presence of right atria1 
spontaneous echocardiographic contrast did not differ between 
patients with acute and chronic atria1 fibrillation with or 
without a recent embolic event. Anticoagulation of any dura- 
tion or ~3 weeks before transesophageal echocardiography 
was significantly more common in patients with chronic than 
acute atria1 fibrillation with or without a recent embolic event. 
Daily aspirin use was infrequent and did not differ among the 
groups. The frequency of mitral stenosis, previous mitral valve 
replacement or moderate or greater impairment in left ven- 
tricular ftinction (i.e., left ventricular ejection fraction 540%) 
did not differ between patients wi‘h acute and chronic atria1 
fibrillation with or without a recent embolic event. Mitral 
regurgitation of moderate or greater severity was common in 
all groups. In patients with a recent embolic event (acute atria1 
fibrillation, n = 24 vs. chronic atria1 fibrillation, n = 52), the 
presence of other potential cardiac etiologies of emboli did not 
differ, such as a patent foramen ovale membrane (8 patients, or 
33% vs. 12 patients, or 25%, p = NS) or left heart vegetation 
(2 patients, or 8% vs. 3 patients, or 6%, p = NS). 
Mobility of tbrombus and systemic emboli: acute versus 
chronic atrial fibrillation. In patients with left atrial throm- 
bus, mobile thrombus was equally common in patients with 
acute (10 [50%] of 20) and chronic (23 [49%] of 47, p = NS) 
atria1 fibrillation. In patients with acute atria1 fibrillation, 
mobile left atria1 thrombus was seen more commonly in those 
with (5 [lOO%] of 5) than in those without (5 [33%) of 15, p < 
0.05) an embolic event. However, in patients with chronic atrial 
fibrillation, the frequency of mobile left atria1 “qmbus did not 
differ between patients with (8 [67%] of 12) ..J without (15 
[430/o] 35, p = NS) an embolic event. MLliivariate analysis 
showed that in patients with acute atria1 fibrillation, mobile left 
atria1 thrombus (p < 0.05), congestive heart failure (p < 0.02), 
coronary artery disease (p < 0.05) and left i-‘ontricular ejection 
fraction ~40% (p < 0.05) were indepel.. .A( predictors of an 
embolic event. No appropriate clink: j ;hocardiographic 
variable was a predictor of an rmF ; event in patients with 
chronic atria1 fibrillation. rn p ier -a with chronic atria1 fibril- 
lation with a left atria1 thrombus (n = 47), 20 were receiving 
therapeutic long-term anticoagulation for a mean duration of 
1,082 2 1,536 days (range 60 to 4,745). Of these 20 patients, 10 
had mobile left atria1 thrsmbus. Only 1 of 20 patients in 
patients with acute atria1 fibrillation with left atria1 thrombus 
was receiving long-term anticoagulation. This patient had an 
immobile thrombus and a prn+etic mitral valve. 
Predictors of left atria1 tbrombus. Multivariate analysis 
was performed in an attempt to identify clinical and trans- 
thoracic echocardiographic indexes that would predict the 
presence of left atrial thrombus on transesophageal echocar- 
diography in patients with acute or chronic atria1 fibrillation. 
Mitral stenosis (p < 0.01) and left ventricular ejection fraction 
140% (p < 0.02) were independent predictors of the presence 
of left atria1 thrombus in patients with acute atria1 fibrillation. 
Age, gender, hypertension, congestive heart failure, coronary 
artery disease, recent embolic event, lack of anticoagulation 
before transesophageal echocardiography, left atria1 diameter, 
prosthetic mitral valve replacement and lack of moderate or 
greater mitral regurgitation were not independent predictors 
of left atria1 thrombus in patients with acute fibrillation. Of the 
20 patients with acute atrial fibrillation and left atria1 throm- 
bus, 10 had a left ventricular ejection fraction ~40% (i.e., 
sensitivity 50%), and 3 had mitral stenosis (i.e., sensitivity 
15%). On the basis of transthoracic echocardiographic find- 
ings, 65% (13 of 20) of patients with acute atria1 fibrillation and 
left atrial thrombus would have been correctly identified as 
JACC Vol. 25, No. 2 STODDARD ET AL. 451 
February 199?:452-9 LEFT ATRIAL APPENDAGE THROMBUS 
being at higher risk for the presence of left atria1 thrombus. 
The specificities of left ventricular ejection fraction >40% and 
no mitral stenosis for no left atrial thrombus in patients with 
acute atria! fibrillation were 76% (93 of 123) and 08S (120 of 
123), respectively. When lift atrial spontaneous echocardio- 
graphic contrast determined by transesophageal echocardiog- 
raphy was entered into the regression model, it became the 
only independent predictor of left atrial thrombus (p < 0.0002) 
in patients with acute atrial fibrillation. Increasing left atrial 
diameter (p < 0.003) and prosthetic mitral valve replacement 
(p < 0.005) were the only independent predictors of the 
presence of left atria1 thrombus in patients with chronic atrial 
fibrillation. The presence of left atrial diameter ~5.0 cm (n = 
27) and/or prosthetic mitral valve (n = 6) in patients with 
chronic atrial fibrillation and left atrial thrombus was 60% (28 
of 47) sensitive for left atrial thrombus. Left atrial diameter 
~5.0 cm and no prosthetic mitral valve was 85% (108 of 127) 
specific for no left atrial thrombus in the chronic group. Left 
atrial spontaneous echocardiographic contrast was not a pre- 
dictor of left atria1 thrombus in subjects with chronic atrial 
fibrillation. 
Power analysis. The minimally detectable difference in 
proportions with a base proportion of 0.20 was 14% for 
patients with acute versus chronic atria1 fibrillation, 16% for 
those with acute versus chronic atrial fibrillation with no 
embolism and 32% for those with acute versus chronic atrial 
fibrillation with embolism. 
Discussion 
Although the mechanism of left atrial thrombus formation 
and subsequent embolization is undoubtedly complex and 
ill-defined, the postulate that atrial fibrillation must persist >2 
to 3 days before left atrial thrombus forms has become widely 
accepted (11). In addition, it is assumed that left atrial 
thrombus forms after the onset of atrial fibrillation and 
embolizes as a result of the dynamic shear forces of the 
circulation, particularly after return in atrial contraction with 
resumption of sinus rhythm. Because of these concepts, car- 
dioversion of atrial fibrillation ~3 days in duration without 
anticoagulation prophylaxis is believed to be safe and is 
commonly performed. However, it is unclear how long it takes 
for thrombi to form in fibrillating atria and probably depends 
on multiple factors such as type of underlying heart disease, 
ventricular function, atrial size and function, and intraatrial 
coagulability. The results of the present study challenge the 
widespread opinion that patients with acute atrial fibrillation 
<3 days in duration are free of left atrial thrombi. Fourteen 
percent of patients with atrial fibrillation <3 days in duration 
in the present study had left atrial thrombi. We are unaware of 
any previous studies reporting the occurrence of left atrial 
appendage thrombus in patients with atrial fibrillation <3 days 
in duration. 
Left atrial thrombus formation. It is possible that left atrial 
thrombus forms in patients with atrial fibrillation within 3 days 
of or before the onset of the arrhythmia. Embolic events may 
occur within 2 to 3 days after electrical cardioversion of atrial 
fibrillation despite lack of atrial thrombus on transesophageal 
echocardiography before cardioversion (13,27.28). Electrical 
cardioversion impairs left atrial appendage function and may 
predispose to thrombus formation (27,29), presumably within 
days of cardioversion and may account for some cardioversion- 
related embolism. These data support the notion that throm- 
bus may form in the left atrium within 3 days. Miigge et al. (30) 
demonstrated left atrial thrombus in 23 patients with sinus 
rhythm. In such patients, it is possible that left atrial append- 
age dysfunction may occur despite the presence of left atrial 
mechanical function and predispose to thrombus formation 
(31). Although in the present study patients with acute atrial 
fibrillation were considered to have atrial fibrillation of new 
onset, it is possible that clinically silent and undocumented 
paroxysmal episodes of atrial fibrillation may have resulted in 
left atrial thrombus formation. 
Predictors of thrombus. Clinical and echocardiographic 
predictors of the presence of left atrial thrombus by transesoph- 
ageal echocardiography differ between patients with acute and 
chronic atrial fibrillation. In patients with acute atria! fbrilla- 
tion, impaired left ventricular function and mitral stenosis 
predispose to left atrial spontaneous echocardiographic con- 
trasi. Although the exact mechanism of left atria1 spontaneous 
echocardiographic contrast is unknown, it may relate to stasis 
of blood flow leading to rouleaux formation by erythrocytes 
(32). Left atrial spontaneous echocardiographic contrast may 
lead to the formation of left atrial thrombus (15.20). However, 
in the present study patients with chronic versus acute atriai 
fibrillation, left atrial spontaneous echocardiographic contrast 
was not an independent predictor of left atrial thrombus. In 
patients with chronic atrial fibrillation, other determinants of 
left atrial thrombus, such as increasing left atrial size, appear to 
play a more important role in the formation of left atrial 
thrombus. Consistent with previous studies (12,14), in the 
present study a greater predilection for thrombus formation 
was found in the left atrium than the right atrium. The factors 
that account for this difference is unknown. Similarly, sponta- 
neous echocardiographic contrast oi^ the right compared with 
the left atrium was less cornmop. These differences may relate 
to left versus right atria1 size, the narrower shape of the left 
atrial appendage predisposing to stasis, anatomic and func- 
tional differences in venous inflow, left versus right ventricular 
function, or the presence and type of atrioventricular valve 
disease. 
Thrombus mobility and embolism. Dislodgment of throm- 
bus from the left atrium into the circulation is the likely cause 
of most systemic embolic episodes in patients with atrial 
fibrillation. In the present study, mobile compared with immo- 
bile left atria1 thrombus was an independent predictor of 
systemic ~~nboiLm in p&tits with acute atrial fibrillation, 
which supports this hypothesis. Multicenter studies have dem- 
onstrated the efficacy of anticoagulation with warfarin for 
decreasing the incidence of ischemic stroke and systemic 
embolism in patients with atrial fibrillation (33). Despite the 
use of warfarin, ischemic strokes may occur in patients with 
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atria1 fibrillation. In the present study, 20 of 47 patients with 
chronic atria1 fibrillation and left atrial thrombus were receiv- 
;ng long-standing therapeutic anticoagulation with warfarin. 
These data suggest that left atria1 thrombus may form in 
patients with atria1 fibrillation despite adequate anti<oagula- 
tion or, once formed, may not resolve after chronic anticoag- 
ulation therapy. This phenomenon may partially explain the 
presence of systemic embolic events in patients with atria1 
fibrillation despite adequate anticoagulation. 
Transthoracic echocardiographic screening. The data from 
the present study show that transthoracic echocardiography is 
not an adequate screening test for left atria1 thrombus or 
spontaneous echocardiographic contrast. The finding of left 
ventricular dysfunction or mitral stenosis in patients with acute 
atria1 fibrillation or of left atrial enlargement in patients with 
chronic atria1 fibrillation is not very useful in predicting a 
high-risk group for the presence of left atria1 thrombus. Left 
atrial thrombus was predicted in only 65% of patients with 
acute atrial fibrillation and left atria1 thrombus by transthoracic 
echocartdiographic criteria. The potential presence of left atria1 
thrombus in patients with acute atrial fibrillation and the 
relatively low sensitivity of transthnr dcic echocardiography 
appear to preclude cardioversion withor’ 5 decks of antico- 
agulation prophylaxis or transesophageal echocardiography to 
exclude the presence of thrombus. The ultimate role of 
transesophageal echocardiography in such patients before 
cardioversion remains controversial (12-14, 21-:$. 
Study limitations. The accuracy of clinically estimating the 
onset of atrial fibrillation based on patient symptoms has not 
been extensively tested. One previous study demonstrated that 
symptoms were predictive of the onset of atrial fibrillation 
87.5% of the time (33). It is possible that some of the patients 
defined as acute in the present study may have had Ionger- 
standing atrial fibrillation. However, several patients had doc- 
umented onset of atrial fibrillation ~3 days in duration with 
findings of left atria1 thrombus. In addition, the study is 
clinically relevant because in practice the onset of atria1 
fibrillation and the decision to perform electrical cardioversion 
without anticoagulation are frequently based on clinical pre- 
sentation and not precise documentation of the onset of atrial 
fibrillation. The decision to administer anticoagulation may 
often relate to clinical conditions, such as mitral stenosis, 
prosthetic heart valve, dilated cardiomyopathy, and not on the 
basis of atrial fibrillation onset. In the present study, the 
frequency of left atria1 thrombus appears somewhat higher 
than that in previous studies reporting an incidence of left 
atrial thrombus in patients with atrial fibrillation of 12% to 
13% (12,13). However, the overall frequency of left atria1 
thrombus in the present study of 21% (67 of 317) is compara- 
ble to that of a recent study showing an incidence of 26% (14). 
In addition, patients with valvular etiologies of atria1 fibrilla- 
tion were not excluded in the present study, unlike some 
previous studies. Pathologic confirmation of left atria1 throm- 
bus was not possible. However, previous studies are consistent 
with transesophageal echocardiography being a sensitive and 
specific test for the detection of left atrial thrombus (30,35,36). 
Not all cerebrovascular accidents in patients with atria1 
fibrillation are cardioembolic. A cardioembolic mechanism 
may exist in as few as 19% to as high as 75% (37-39). Silent or 
subclinical stroke occurs in atrial fibrillation (40). How these 
factors may have affected the results of the present sIudy are 
unknown. Left ventricular function was qualitatively assessed. 
Previous studies have demonstrated that the qualitative assess- 
ment of left ventricular function by two-dimensional echocar- 
diography can be performed with reasonable accuracy. The 
number of patients with mitral stenosis and prosthetic mitral 
valves was small, which limits generalization of conclusions to 
these groups of patients with atria1 fibrillation. 
Only patients referred to the laboratory for transesophageal 
echocardiography were enrolled. Therefore, selection bias 
cannot be excluded. Left atria1 appendage function was not 
assessed in the present study. Such measuremrrus n i -’ ,
tribute to the understanding of left atrial thrombr~: ! inr t,id,n 
in patients with atria1 fibrillation (31,41). The deinution OF the 
duration of acute fibrillation is arbitrary. The results of the 
present study would not have changed substantially if ~2 d+ys 
had been used as the definition of acute atrial fibrillation. 
Conclusions. Left atria1 thrombus occurs in an important 
number of patients with acute atria1 fibrillation and is usually 
confined to the left atria1 appendage. Mobile left atrial ap- 
pendage thrombus is an independent risk factor for emboli in 
patients with acute atria1 fibrillation. The hypothesis that 
patients with atrial fibrillation of <3 days in duration are free 
of thrombus should no longer be accepted. Anticoagulation 
prophylaxis should be considered in patients with acute atria1 
fibrillation before cardioversion, particularly if risk factors for 
thrombi or emboli exist. Although the role of transesophageal 
echocardiography in such patients remains unproved, it ap- 
pears reasonable to perform transesophageal echocardiogra- 
phy before cardioversion in patients with acute atria1 fibrilla- 
tion who are not to receive anticoagulation prophylaxis of 3 
weeks in duration. 
We appreciate the secretarial assistance of Erica Camp in the preparation of the 
manuscript and the statistical assistance of Linda J. Goldsmith, PhD. 
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